Scarica l'app Stockscreener
32.89
23.32%
-10.00
Dopo l'orario di chiusura:
31.75
-1.14
-3.47%
Precedente Chiudi:
$42.89
Aprire:
$37.402
Volume 24 ore:
5.12M
Relative Volume:
3.34
Capitalizzazione di mercato:
$1.23B
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-0.5433
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
-5.24%
1M Prestazione:
+32.35%
6M Prestazione:
+108.03%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$32.35
$40.25
Intervallo di 1 settimana:
$32.35
$44.12
Portata 52W:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
(833) 694-2553
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
32.89 | 1.23B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
406.05 | 153.96B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
187.82 | 138.19B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.42 | 39.13B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.52 | 30.65B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.82 | 26.52B | 15.50B | 1.33B | 2.16B | 7.34 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
Gravity study shows why the moon's two sides look so different - marketscreener.com
Health Care Sector Slips While Incannex Rockets Ahead - Finimize
Sector Update: Health Care - marketscreener.com
GRAIL and athenahealth partner to simplify ordering of cancer detection test - MSN
GRAIL outlines 2025 commercial growth plans and targets up to 30% US Galleri revenue increase - MSN
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Grail partners with athenahealth for MCED test ordering - Yahoo Finance
Grail price target raised to $43 from $32 at Canaccord - TipRanks
GRAIL stock price target raised to $43 by Canaccord Genuity - Investing.com South Africa
GRAIL Inc Reports Q1 2025 Earnings: Revenue Hits $31.8 Million A - GuruFocus
Earnings call transcript: Grail Inc Q1 2025 sees revenue growth, stock tumbles - Investing.com Nigeria
After-hours movers: American Eagle Outfitters, Aurora, GRAIL By Investing.com - Investing.com India
GRAIL Earnings Results: $GRAL Reports Quarterly Earnings - Nasdaq
GRAIL falls 16% after Q1 topline miss - MSN
GRAIL falls 16% after Q1 topline miss (GRAL:NASDAQ) - Seeking Alpha
Grail Inc reports results for the quarter ended March 31Earnings Summary - TradingView
GRAIL Reports First Quarter 2025 Financial Results - TradingView
GRAIL shares tumble as Q1 loss persists despite revenue growth - Investing.com Australia
GRAIL shares tumble as Q1 loss persists despite revenue growth By Investing.com - Investing.com India
Grail reports Q1 EPS ($3.10), consensus ($3.80) - TipRanks
Earnings Flash (GRAL) GRAIL INC. Posts Q1 Revenue $31.8M, vs. FactSet Est of $35.2M - marketscreener.com
GRAIL And Athenahealth Partner To Streamline Galleri Multi-Cancer Test Ordering - Nasdaq
GRAIL, athenahealth partner for cancer test (GRAL:NASDAQ) - Seeking Alpha
GRAIL partners with athenahealth for cancer test orders By Investing.com - Investing.com India
Wells Fargo & Company MN Takes $90,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL partners with athenahealth for cancer test orders - Investing.com Australia
Grail And Athenahealth Team Up To Offer Healthcare Providers Streamlined Ordering Of Grail's Galleri® Multi-Cancer Early Detection (Mced) Test - marketscreener.com
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test - PR Newswire
Stifel Financial Corp Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
Barclays PLC Purchases Shares of 24,107 Grail, Inc. (NASDAQ:GRAL) - Defense World
Raymond James Financial Inc. Takes $476,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
SEC ends probe of Illumina’s Grail acquisition - MedTech Dive
Illumina confirms SEC has closed investigation into $8B Grail deal - Endpoints News
Mariner LLC Makes New $190,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
Envestnet Asset Management Inc. Buys New Shares in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail’s CFO Aaron Freidin sells $1.4 million in stock By Investing.com - Investing.com Nigeria
Grail’s CFO Aaron Freidin sells $1.4 million in stock - Investing.com Australia
Lobbying Update: $500,000 of GRAIL INC. (FORMERLY GRAIL LLC) lobbying was just disclosed - Nasdaq
JPMorgan Chase & Co. Sells 48,591 Shares of Grail, Inc. (NASDAQ:GRAL) - Defense World
Why GRAIL, Inc. (GRAL) is Surging in 2025 - Insider Monkey
GRAIL to Announce First Quarter 2025 Financial Results - The Victoria Advocate
LPL Financial LLC Invests $244,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL to Reveal Latest Cancer Detection Financial Performance: Q1 2025 Results Coming May 13 - Stock Titan
CEO Sam Hazen on where technology will be HCA's 'holy grail' - The Business Journals
GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting - PR Newswire
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
Opinion | The FTC vs. the War on Cancer - WSJ
This Cancer Test Could Become Routine—and a Big Seller, Says Analyst - Barron's
Canaccord starts Grail with a Buy, sees ‘solid upside’ - TipRanks
Canaccord sets $32 target on GRAIL stock with buy rating By Investing.com - Investing.com Nigeria
Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target - marketscreener.com
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):